• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $APGE

    Apogee Therapeutics Inc.

    Subscribe to $APGE
    $APGE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    IPO Year: 2023

    Exchange: NASDAQ

    Recent Analyst Ratings for Apogee Therapeutics Inc.

    DatePrice TargetRatingAnalyst
    3/13/2025$95.00Buy
    Citigroup
    11/25/2024$89.00Buy
    Canaccord Genuity
    5/10/2024$80.00Buy
    BofA Securities
    12/20/2023$43.00Buy
    BTIG Research
    8/8/2023Outperform
    TD Cowen
    8/8/2023$40.00Outperform
    Wedbush
    8/8/2023$29.00Buy
    Guggenheim
    8/8/2023$34.00Buy
    Stifel
    8/8/2023$29.00Buy
    Jefferies
    See more ratings